Tesamorlin 5mg

Tesamorelin is a synthetic peptide and an analog of human growth-hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release natural growth hormone. 

How It Works

• Upstream signaling: Unlike direct synthetic growth hormone injections, tesamorelin preserves the body's natural pulsatile release rhythm. 
• Fat metabolism: Increased growth hormone raises insulin-like growth factor 1 (IGF-1) levels, which targets and reduces deep visceral adipose tissue (the fat surrounding internal abdominal organs). 

Medical Uses and Benefits

• FDA approval: It is approved by the U.S. Food and Drug Administration (FDA) under brand names like Egrifta SV to reduce excess abdominal belly fat in adults with HIV-associated lipodystrophy. 
• Visceral fat reduction: Clinical trials show an average 10% to 18% reduction in visceral fat over 26 weeks of treatment. 
• Off-label research: Clinicians sometimes explore it off-label for general metabolic optimization, body composition support, and nonalcoholic fatty liver disease (NAFLD)